J. B. Schwartz

727 total citations
21 papers, 568 citations indexed

About

J. B. Schwartz is a scholar working on Pharmaceutical Science, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, J. B. Schwartz has authored 21 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 4 papers in Analytical Chemistry. Recurrent topics in J. B. Schwartz's work include Drug Solubulity and Delivery Systems (9 papers), Analytical Methods in Pharmaceuticals (4 papers) and Advanced Drug Delivery Systems (4 papers). J. B. Schwartz is often cited by papers focused on Drug Solubulity and Delivery Systems (9 papers), Analytical Methods in Pharmaceuticals (4 papers) and Advanced Drug Delivery Systems (4 papers). J. B. Schwartz collaborates with scholars based in United States, Belgium and Czechia. J. B. Schwartz's co-authors include Robert E. O’Connor, DR Abernethy, J.P. Remon, C. T. Rhodes, N. R. Bohidar, Hans S.L.M. Nottet, Marti Jett, Edward W. Bernton, Yuri Persidsky and Angie Rizzino and has published in prestigious journals such as The Journal of Immunology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

J. B. Schwartz

20 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. B. Schwartz United States 13 292 96 91 84 75 21 568
Gary W. Pace United States 10 127 0.4× 71 0.7× 20 0.2× 175 2.1× 13 0.2× 16 795
Pramod Yeole India 12 416 1.4× 24 0.3× 67 0.7× 119 1.4× 9 0.1× 26 559
Prabhakar Kandadi India 12 402 1.4× 26 0.3× 59 0.6× 180 2.1× 8 0.1× 15 609
Pankaj Nerkar India 9 264 0.9× 18 0.2× 38 0.4× 78 0.9× 4 0.1× 21 402
Shagufta Khan India 11 377 1.3× 23 0.2× 64 0.7× 80 1.0× 5 0.1× 20 506
Moji Christianah Adeyeye United States 15 405 1.4× 5 0.1× 69 0.8× 82 1.0× 4 0.1× 33 645
Narendra Chotai India 10 286 1.0× 13 0.1× 49 0.5× 90 1.1× 5 0.1× 20 379
Hiroyasu Kokubo Japan 11 252 0.9× 8 0.1× 45 0.5× 69 0.8× 1 0.0× 18 395
Basanth Babu Eedara India 17 455 1.6× 6 0.1× 88 1.0× 107 1.3× 2 0.0× 32 793
Panchaxari M. Dandagi India 19 579 2.0× 3 0.0× 58 0.6× 141 1.7× 5 0.1× 78 878

Countries citing papers authored by J. B. Schwartz

Since Specialization
Citations

This map shows the geographic impact of J. B. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. B. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. B. Schwartz more than expected).

Fields of papers citing papers by J. B. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. B. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. B. Schwartz. The network helps show where J. B. Schwartz may publish in the future.

Co-authorship network of co-authors of J. B. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of J. B. Schwartz. A scholar is included among the top collaborators of J. B. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. B. Schwartz. J. B. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Reilly, William J., et al.. (1994). Reprocessing of Microcrystalline Cellulose Spheres with Low Drug Concentrations. Drug Development and Industrial Pharmacy. 20(8). 1511–1515. 1 indexed citations
4.
Skelly, Jerome P., Gordon L. Amidon, Shrikant V. Dighe, et al.. (1993). SCALE-UP OF IMMEDIATE RELEASE ORAL SOLID DOSAGE FORMS. PDA Journal of Pharmaceutical Science and Technology. 47(2). 52–56. 6 indexed citations
5.
Skelly, Jerome P., Gordon L. Amidon, Shrikant V. Dighe, et al.. (1993). Scaleup of immediate release oral solid dosage forms.. Pharmaceutical Research. 10(2). 313–316. 23 indexed citations
6.
Wigent, Rodney J., et al.. (1990). Autohesion in Pharmaceutical Solids. Drug Development and Industrial Pharmacy. 16(16). 2383–2407. 11 indexed citations
7.
Schwartz, J. B., et al.. (1990). The Strength of Microcrystalline Cellulose Pellets: The Effect of Granulating with Water/Ethanol Mixtures. Drug Development and Industrial Pharmacy. 16(8). 1411–1426. 95 indexed citations
8.
Remon, J.P., et al.. (1988). The Dissolution Rate and Bioavailability of Hydrochlorothiazide in Pellet Formulations. Journal of Pharmacy and Pharmacology. 40(3). 157–160. 12 indexed citations
9.
Remon, Jean Paul, et al.. (1988). Formation of theophylline monohydrate during the pelletisation of microcrystalline cellulose-anhydrous theophylline blends. International Journal of Pharmaceutics. 42(1-3). 15–18. 39 indexed citations
10.
Remon, J.P. & J. B. Schwartz. (1987). Effect of Raw Materlals and Processing on the Quality of Granules Prepared from Microcrystalline Cellulose-Lactose Mixtures. Drug Development and Industrial Pharmacy. 13(1). 1–14. 21 indexed citations
11.
Schwartz, J. B., et al.. (1985). An investigation of the cause of accumulation of verapamil during regular dosing in patients.. British Journal of Clinical Pharmacology. 19(4). 512–516. 24 indexed citations
12.
O’Connor, Robert E. & J. B. Schwartz. (1985). Spheronization II: Drug Release from Drug-Diluent Mixtures. Drug Development and Industrial Pharmacy. 11(9-10). 1837–1857. 75 indexed citations
13.
Harris, Michael, J. B. Schwartz, & James W. McGinity. (1985). Optimization of a Slow-Release Tablet Formulation Containing Sodium Sulfathiazole and a Montmorillonite Clay. Drug Development and Industrial Pharmacy. 11(5). 1089–1110. 16 indexed citations
14.
Abernethy, DR, et al.. (1985). Caffeine disposition in obesity.. British Journal of Clinical Pharmacology. 20(1). 61–66. 39 indexed citations
15.
Schwartz, J. B., et al.. (1983). Optimization techniques: Studies in cell culture. Drug Development and Industrial Pharmacy. 9(5). 745–766. 6 indexed citations
16.
Rhodes, C. T., et al.. (1982). Some Studies on Compression Properties of Tablet Matrices Using a Computerized Instrumented Press. Drug Development and Industrial Pharmacy. 8(1). 63–86. 24 indexed citations
17.
Rhodes, C. T., et al.. (1981). Some Effects of Relatively Low Levels of Eight Tablet Disintegrants on a Direct Compression System. Drug Development and Industrial Pharmacy. 7(3). 347–358. 12 indexed citations
18.
Bohidar, N. R., et al.. (1979). Selecting Key Pharmaceutical Formulation Factors by Regression Analysis. Drug Development and Industrial Pharmacy. 5(2). 175–216. 12 indexed citations
19.
Bohidar, N. R., et al.. (1975). Selecting Key Parameters in Pharmaceutical Formulations by Principal Component Analysis. Journal of Pharmaceutical Sciences. 64(6). 966–969. 18 indexed citations
20.
Schwartz, Benjamin & J. B. Schwartz. (1961). A review of the biochemistry and pharmacology of alpha-chymotrypsin.. PubMed. 2. 269–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026